Mazzoni Center Behavioral Health Services

Services:
Treatment Approaches
• Substance use disorder counseling
• Relapse prevention
• Motivational interviewing
• Brief intervention
• Telemedicine/telehealth therapy
• 12-step facilitation
• Cognitive behavioral therapy
• Trauma-related counseling

License/Certification/Accreditation

• State department of health
• State Substance use treatment agency

Type of Opioid Treatment

• Prescribes naltrexone
• Buprenorphine maintenance
• Prescribes buprenorphine
• Relapse prevention with naltrexone
• Accepts clients using MAT but prescribed elsewhere

Type of Care

• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
• Substance use treatment

Gender Accepted

• Female
• Male

Pharmacotherapies

• Clonidine
• Medication for mental disorders
• Buprenorphine without naloxone
• Buprenorphine with naloxone
• Acamprosate (Campral®)
• Naltrexone (oral)
• Medications for pre-exposure to prophylaxis
• Non-nicotine smoking/tobacco cessation
• Naltrexone (extended-release, injectable)
• Nicotine replacement
• Disulfiram

Age Groups Accepted

• Adults
• Children/Adolescents

Transitional Services

• Discharge Planning
• Naloxone and overdose education
• Aftercare/continuing care

Other Services

• Treatment for gambling disorder
• Treatment for other addiction disorder

Education and Counseling Services

• Marital/couples counseling
• Individual counseling
• Substance use disorder education
• HIV or AIDS education, counseling, or support
• Smoking/vaping/tobacco cessation counseling
• Family counseling
• Hepatitis education, counseling, or support
• Health education services other than HIV/AIDS or hepatitis
• Group counseling

Special Programs/Groups Offered

• Clients with HIV or AIDS
• Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)

External Source of Medications Used for Alcohol Use Disorder Treatment

• No formal relationship with prescribing entity
• Other contracted prescribing entity
• In-network prescribing entity

Assessment/Pre-treatment

• Screening for mental disorders
• Screening for substance use
• Comprehensive mental health assessment
• Comprehensive substance use assessment
• Interim services for clients
• Screening for tobacco use
• Outreach to persons in the community

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Regular outpatient treatment
• Outpatient methadone/buprenorphine or naltrexone treatment
• Intensive outpatient treatment
• Outpatient

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder
• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

Recovery Support Services

• Self-help groups
• Assistance with obtaining social services
• Mentoring/peer support
• Recovery coach

External Opioid Medications Source

• No formal relationship with prescribing entity
• Other contracted prescribing entity
• In-network prescribing entity

Facility Vaping Policy

• Vaping not permitted

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

Medical Services

• Hepatitis B (HBV) vaccination
• Hepatitis A (HAV) vaccination

Payment Assistance Available

• Sliding fee scale (fee is based on income and other factors)

Ancillary Services

• Mental health services
• Integrated primary care services
• Early intervention for HIV
• Case management service

Facility Smoking Policy

• Smoking not permitted

Payment/Insurance/Funding Accepted

• Federal, or any government funding for substance use treatment programs
• Medicare
• Private health insurance
• Cash or self-payment
• Medicaid

Testing

• HIV testing
• Drug or alcohol urine screening
• STD testing